Literature DB >> 22844865

Aberrant expression levels of MTA1 and RECK in nasopharyngeal carcinoma: association with metastasis, recurrence, and prognosis.

Yan Fei Deng1, Dong Ni Zhou, Chun Sheng Ye, Liang Zeng, Ping Yin.   

Abstract

OBJECTIVES: We investigated the expression and clinical value of MTA1 and RECK genes in patients with nasopharyngeal carcinoma (NPC).
METHODS: We examined MTA1 and RECK expression in nasopharyngeal tissue from patients with chronic nasopharyngitis, lymph nodes with metastasis of NPC, and primary NPC tumor tissue by means of in situ hybridization and analyzed their correlation with the clinicopathologic features of NPC.
RESULTS: The positive expression of MTA1 in the NPC tissues and metastatic lymph nodes was significantly higher than that in the chronic nasopharyngitis tissues (p < 0.05). The positive expression of RECK in the NPC tissues and metastatic lymph nodes was significantly lower than that in the chronic nasopharyngitis tissues (p < 0.05). The RECK expression level was inversely correlated with the MTA1 expression level in the NPC tissues (p < 0.05). The increased MTA1 and decreased RECK expressions in the NPC tissues had no association with gender, age, T-stage, or clinical stage (p > 0.05). However, they had a positive correlation with cervical lymph node metastasis, tumor recurrence, and 5-year overall survival rate of the patients with NPC (p < 0.05). Moreover, multivariate analysis showed that MTA1 and RECK expressions were independent prognostic factors for survival (p < 0.05).
CONCLUSIONS: The conversely abnormal expression levels of MTA1 and RECK may be collectively involved in progression of malignancies and may serve as molecular predictors for metastasis, recurrence, and prognosis of NPC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22844865     DOI: 10.1177/000348941212100706

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  7 in total

1.  Clinical significance of RECK promoter methylation in pancreatic ductal adenocarcinoma.

Authors:  Xiong-Xiong Lu; Shu-Min Zhang; Yuan Fang; Zheng-Ting Wang; Jun-Jie Xie; Qian Zhan; Xia-Xing Deng; Hao Chen; Jia-Bin Jin; Cheng-Hong Peng; Hong-Wei Li; Bai-Yong Shen
Journal:  Tumour Biol       Date:  2013-06-08

2.  Expression of MTA1 in nasopharyngeal carcinoma and its correlation with prognosis.

Authors:  Taize Yuan; Huanhuan Zhang; Baoqiong Liu; Qiong Zhang; Yin Liang; Ronghui Zheng; Jin Deng; Xiuping Zhang
Journal:  Med Oncol       Date:  2014-11-22       Impact factor: 3.064

3.  Concurrent alterations of RAGE, RECK, and MMP9 protein expression are relevant to Epstein-Barr virus infection, metastasis, and survival in nasopharyngeal carcinoma.

Authors:  Dong-Ni Zhou; Yan-Fei Deng; Rong-Hua Li; Ping Yin; Chun-Sheng Ye
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

4.  Metastasis-associated protein 1 as a new prognostic marker for solid tumors: a meta-analysis of cohort studies.

Authors:  Haiqing Luo; Hongjiao Li; Na Yao; Liren Hu; Taiping He
Journal:  Tumour Biol       Date:  2014-03-06

Review 5.  MTA1--a stress response protein: a master regulator of gene expression and cancer cell behavior.

Authors:  Rui-An Wang
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

6.  Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers: A meta-analysis.

Authors:  Ke Ma; Yangwei Fan; Yuan Hu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo.

Authors:  Qingcui Song; Hong Zhang; Min Wang; Wen Song; Min Ying; Yuan Fang; Yiyi Li; Yilan Chao; Xiaoxia Zhu
Journal:  J Exp Clin Cancer Res       Date:  2013-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.